[Efficacy of early intensive behavioral intervention in autism spectrum disorders]
Gonzalez L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32015000868
Spanish
Authors' objectives:
To assess the available evidence on the efficacy, safety and issues related to coverage policies for the use of early intensive behavioral interventions in patients with autism spectrum disorder.
Authors' recommendations:
The quality of the evidence found is low. It shows that an EIBI program could yield an improvement on different ASD features. However, with the methodology used in the studies, it is not possible to establish whether EIBI is better than the other treatments or not, which elements of therapy are responsible for these benefits, the best starting age, the frequency and duration of the program, which subgroup of children may benefit, long-term duration of benefits, or if they translate into a quality of life improvement. There is consensus among the different international societies to consider EIBI as an alternative for ASD treatment. ASD treatment coverage is mandatory in different countries and jurisdictions in compliance with local regulations, although it is not yet clear which treatment or methodologies should be used.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Behavior Therapy
- Early Intervention, Educational
- Autistic Disorder
- Child
- Child Development Disorders, Pervasive
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.